Direxion Daily Biotech Top 5 Bull 2X ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBXU and other ETFs, options, and stocks.

About TBXU

TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. 

Index-Tracked
NYSE Biotechnology TR USD
Index-TrackedNYSE Biotechnology TR USD
Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
9
Number of holdings9
Inception Date
Sep 30, 2025
Inception DateSep 30, 2025

TBXU Key Statistics

AUM
3.59M
AUM3.59M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
5.45K
Average volume5.45K
High today
$33.81
High today$33.81
Low today
$33.19
Low today$33.19
Open price
$33.81
Open price$33.81
Volume
2.92K
Volume2.92K
52 Week high
$38.89
52 Week high$38.89
52 Week low
$25.71
52 Week low$25.71
Expense ratio
0.99
Expense ratio0.99

Stock Snapshot

As of today, Direxion Daily Biotech Top 5 Bull 2X ETF(TBXU) shares are valued at $33.55. The company's market cap stands at 4.14M.

On 2025-12-04, Direxion Daily Biotech Top 5 Bull 2X ETF(TBXU) stock moved within a range of $33.19 to $33.81. With shares now at $33.55, the stock is trading +1.1% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 2.92K, compared to an average daily volume of 5.45K.

Over the past 52 weeks, Direxion Daily Biotech Top 5 Bull 2X ETF(TBXU) stock has traded between a high of $38.89 and a low of $25.71.

Over the past 52 weeks, Direxion Daily Biotech Top 5 Bull 2X ETF(TBXU) stock has traded between a high of $38.89 and a low of $25.71.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.